Neoadjuvant Immunotherapy Improves Treatment for Early Resectable Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis.
Peng DongYu YanLiyuan YangDanzhu WuHui WangYajuan LvJiandong ZhangXinshuang YuPublished in: Journal of oncology (2022)
Neoadjuvant immunotherapy is safe and effective for resectable NSCLC.